S. Hahn

Long-term outcomes of phase I/II prospective study of dose-escalated proton therapy for early-stage non-small cell lung cancer

Joe Y. Chang, R. Mohan, Xiaodong Zhang, 2017 .

Changing clinical course of patients with malignant mesothelioma: Implications for FNA cytology and utility of immunocytochemical staining

J. Friedberg, L. Soma, S. Hahn, 2001, Diagnostic cytopathology.

Effectiveness of androgen-deprivation therapy and radiotherapy for older men with locally advanced prostate cancer.

K. Armstrong, D. Polsky, N. Mitra, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions.

Charles R. Thomas, Mack Roach, Sucha Asbell, 2007, International journal of radiation oncology, biology, physics.

Promoter Polymorphism Is Prognostic of the Overall Survival in Patients with Non – Small Cell Lung Cancer ( NSCLC ) Receiving

Z. Liao, L. Levy, Yipeng Song, 2017 .

Laparoscopic-assisted application of interstitial brachytherapy for locally advanced cervical carcinoma: results of a pilot study.

M. Piver, F. Recio, G. Eltabbakh, 1998, International journal of radiation oncology, biology, physics.

Effectiveness of androgen-deprivation therapy and radiotherapy for older men with locally advanced prostate cancer.

K. Armstrong, D. Polsky, N. Mitra, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.